HER2-negative Breast Cancer Patients With Brain Metastases trials recruiting in Illinois

Fewer than 3 recruiting trials found.

All HER2-negative Breast Cancer Patients With Brain Metastases trials nationally

Cities in Illinois

Recruiting trials in Illinois

• A Pivotal Phase II Clinical Trial of Utidelone Injection Plus Capecitabine in HER2-negative Breast Cancer Patients With Brain Metastases
  NCT06764940 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · Illinois: Chicago